Nonprofit buys experimental cancer drug to maintain patient access - Top-Institutions - MDSpire

Nonprofit buys experimental cancer drug to maintain patient access

  • By

  • Lauren Chan

  • June 11, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Stanford University
    Stanford University

    Stanford, CA

    Key Differentiators

    • Oncology

  • #2

    National Cancer Institute
    National Cancer Institute

    Bethesda, MD

    Key Differentiators

    • Oncology

  • #3

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Oncology

  • #4

    Seattle Cancer Care Alliance
    Seattle Cancer Care Alliance

    Seattle, WA

    Key Differentiators

    • Oncology

  • #5

    University of Michigan Medical School
    University of Michigan Medical School

    Ann Arbor, MI

    Key Differentiators

    • Oncology

Original Source(s)

Nonprofit buys experimental cancer drug to maintain patient access

  • by Lauren Chan

  • June 11, 2026

Related Content

Global research trends and hotspots in human immunodeficiency virus-associated cervical cancer (1990–2025): a multi-database bibliometric analysis

Correction: Converting an immunologically “cold” tumor: Exceptional response to cadonilimab plus chemotherapy in microsatellite-stable pancreatic cystadenocarcinoma

Primary large cell neuroendocrine carcinoma of the breast with metastasis in the lymph nodes: a case report and literature review